Skip to main content

Additional Articles by the Author

Byron C. Scott, MD, MBA
Nihar R. Desai, MD, MPH; Pamala Reed, DrPH, MPH; Paula J. Alvarez, RPh, MBA, MPH; Jeanene Fogli, PhD, RD; Steven D. Woods, PharmD; Mary Kay Owens, RPh, CPh
The Impact of Quality Care on a Medicaid Population with Hyperkalemia
Byron C. Scott, MD, MBA
Raghu Durvasula, MD, MHA; Janet Kelly, PharmD; Anneliese Schleyer, MD, MHA; Bradley D. Anawalt, MD; Shabir Somani, MS, MBA, RPh, FASHP; Timothy H. Dellit, MD
Pharmacy & Therapeutics Committees’ New Challenge: Stewardship for Specialty Drugs
Byron C. Scott, MD, MBA
Christopher B. Atzinger, MS, PhD candidate; Jeff J. Guo, BPharm, PhD
Rheumatoid Arthritis, Biologic Drugs, and Associated Cost
Byron C. Scott, MD, MBA
Health Plan Subsidies, Prescription Drugs, and Cost
Implementing Payment Reform in Oncology: Benefits and Challenges

Results 1 - 7 of 7